ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Pennsylvania » Geriatric Medicine

Top Geriatric Medicine Prescribers in Pennsylvania

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
EMILY JAFFE MD

Geriatric Medicine

17,632

$3,749

236
203 are 65+

13%
patients receiving schedule two controlled substances

Avg: 14%

20%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 24%

$0
Average prescription price

Avg: $50

DALMA HEGEDUS M.D.

Geriatric Medicine

23,683

$372

175
165 are 65+

23%
patients receiving schedule two controlled substances

Avg: 14%

27%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 24%

$0
Average prescription price

Avg: $50

EMMANUEL OKOLO MD

Geriatric Medicine

16,698

$884K

515
350 are 65+

13%
patients receiving schedule two controlled substances

Avg: 14%

4%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$53
Average prescription price

Avg: $50

BOHDAN MARTYNEC M.D.

Geriatric Medicine

13,836

$877K

672
627 are 65+

7%
patients receiving schedule two controlled substances

Avg: 14%

5%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$63
Average prescription price

Avg: $50

SUPRIYO GHOSH MD

Geriatric Medicine

8,955

$599K

526
471 are 65+

6%
patients receiving schedule two controlled substances

Avg: 14%

5%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$67
Average prescription price

Avg: $50

FAINA CAPLAN MD

Geriatric Medicine

11,440

$544K

328
319 are 65+

12%
patients receiving schedule two controlled substances

Avg: 14%

4%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $50

DANIEL HAIMOWITZ MD

Geriatric Medicine

12,396

$537K

354
340 are 65+

8%
patients receiving schedule two controlled substances

Avg: 14%

11%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$43
Average prescription price

Avg: $50

RAJESH KUMAR M.D.

Geriatric Medicine

12,187

$495K

303
289 are 65+

18%
patients receiving schedule two controlled substances

Avg: 14%

N/A

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$41
Average prescription price

Avg: $50

GERARD MILLER M.D.

Geriatric Medicine

7,330

$479K

268
252 are 65+

9%
patients receiving schedule two controlled substances

Avg: 14%

N/A

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$65
Average prescription price

Avg: $50

MICHAEL GLUCK MD

Geriatric Medicine

4,118

$440K

236
199 are 65+

13%
patients receiving schedule two controlled substances

Avg: 14%

16%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 24%

$107
Average prescription price

Avg: $50

JOEL POSNER MD

Geriatric Medicine

7,055

$438K

407
407 are 65+

6%
patients receiving schedule two controlled substances

Avg: 14%

5%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $50

ALFRED STILLMAN MD

Geriatric Medicine

10,014

$418K

339
291 are 65+

12%
patients receiving schedule two controlled substances

Avg: 14%

12%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$42
Average prescription price

Avg: $50

FRED RUBIN MD

Geriatric Medicine

6,316

$407K

300
295 are 65+

7%
patients receiving schedule two controlled substances

Avg: 14%

6%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$64
Average prescription price

Avg: $50

DOROTHY CANDIB MD

Geriatric Medicine

7,265

$360K

235
234 are 65+

42%
patients receiving schedule two controlled substances

Avg: 14%

9%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $50

SUSAN SCHWARTZ M. D.

Geriatric Medicine

5,809

$348K

131
109 are 65+

19%
patients receiving schedule two controlled substances

Avg: 14%

13%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 24%

$60
Average prescription price

Avg: $50

THOMAS BRANDECKER MD

Geriatric Medicine

5,801

$334K

294
280 are 65+

N/A
N/A

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$58
Average prescription price

Avg: $50

ROBERT FURIA MD

Geriatric Medicine

6,116

$326K

187
168 are 65+

19%
patients receiving schedule two controlled substances

Avg: 14%

N/A

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$53
Average prescription price

Avg: $50

CATHERINE GRUER MD

Geriatric Medicine

6,803

$320K

161
126 are 65+

32%
patients receiving schedule two controlled substances

Avg: 14%

N/A

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$47
Average prescription price

Avg: $50

NAMITA AHUJA MD

Geriatric Medicine

6,440

$299K

220
212 are 65+

20%
patients receiving schedule two controlled substances

Avg: 14%

14%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$46
Average prescription price

Avg: $50

LESLEY CARSON MD

Geriatric Medicine

6,845

$298K

325
311 are 65+

8%
patients receiving schedule two controlled substances

Avg: 14%

3%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$44
Average prescription price

Avg: $50

CATHERINE CLARKE M.D.

Geriatric Medicine

4,209

$296K

261
237 are 65+

6%
patients receiving schedule two controlled substances

Avg: 14%

N/A

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$70
Average prescription price

Avg: $50

MARY MUSUKU M.D

Geriatric Medicine

5,549

$275K

257
198 are 65+

19%
patients receiving schedule two controlled substances

Avg: 14%

N/A

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $50

CHARLES BREISH M.D.

Geriatric Medicine

4,535

$209K

322
305 are 65+

16%
patients receiving schedule two controlled substances

Avg: 14%

N/A

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$46
Average prescription price

Avg: $50

LYNSEY BRANDT MD

Geriatric Medicine

3,297

$167K

217
214 are 65+

11%
patients receiving schedule two controlled substances

Avg: 14%

N/A

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$51
Average prescription price

Avg: $50

DONNA RAZIANO MD MBA

Geriatric Medicine

10,982

$558

275
251 are 65+

14%
patients receiving schedule two controlled substances

Avg: 14%

5%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$0
Average prescription price

Avg: $50

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank